Facts of Zolinza (vorinostat) capsules 100mg ?
- Medicine Name: Zolinza
- Generic Name: Vorinostat
- Approval Date: October 6, 2006
- Company Name: Merck & Co., Inc
- Available as (Form & Strength): Capsules 100mg
ZOLINZA is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous manifestations in patients with cutaneous T – cell lymphoma (CTCL) who have progressive, persistent or recurrent disease on or following two systemic therapies .